Elan Corp. will realign itself to focus more resources on its pipeline. Concrete plans have not been released, but the company plans to cut a number of positions and “additional refinement to Elan’s commercial activities in Tysabri for Crohn’s disease,” according to a company statement. Elan will close its offices in New York and Tokyo during the 1Q09. Elan’s chief executive officer Kelly Martin said that the changes have been under evaluation for several months, remarking, ...